volvement of CDK2 in cisplatin-induced cell death in vivo and in vitro (13, 18) , and inhibition of CDK2 by p21 protects from cisplatin-induced injury (11, 12, 17) . Of interest, deletion of the nuclear localization signal from p21 does not alter its protective action against cisplatin cytotoxicity (17) , suggesting that the protective interaction between p21 and CDK2 may not occur in the nucleus. Indeed, active cdk2-cyclin complexes are detected in both nucleus and cytoplasm (7), and translocation of cdk2 from the nucleus to the cytoplasm was reported to occur after the apoptotic stimulus (5). This finding is intriguing, as CDK2 is a cell cycle regulator, and by default, active CDK2 is expected to reside in the nucleus. Yu et al. (19) demonstrate the presence of cdk2 activity in cytoplasts, and as was observed in nucleated cells (13, 18) , inhibition of cdk2 in cytoplasts blocked cisplatin-induced apoptosis. These data suggest that cisplatin-induced apoptosis may be initiated from the cytoplasm, in a manner that does not require nuclear contribution. Additionally, they find that cdk2 localizes to the ER and Golgi compartments, suggesting that phosphorylation of substrates in these compartments by CDK2 in response to cisplatin may play an important role in cisplatin-induced cytotoxicity and that CDK2 activity may be critical for cell death signaling originating from the endoplasmic reticulum (ER). Accordingly, inhibition of CDK2 in cytoplasts attenuates ER stress induced by various stressors, such as tunicamycin, which inhibits N-glycosylation, brefeldin A, which causes disassembly of the Golgi and accumulation of secretory proteins in the ER, and thapsigargin, which inhibits the ER Ca 2ϩ -ATPase. Cumulatively, the data by Yu et al. (19) demonstrate that while cisplatin cytotoxicity may be augmented by nuclear events, it may be initiated from the cytoplasm; cdk2 activity, which normally promotes cell cycle progression, is important for promoting apoptosis in response to cisplatin; and finally, subcellular localization of cdk2 may determine its substrate specificity, which in turn determines cell fate. Thus CDK2 may regulate a critical checkpoint in stressed cells; determining whether the cells are viable, and hence can proliferate, or are damaged, and hence committed to apoptosis.
